When we say someone has a big heart, they are kind and generous, love to give and help others and bring joy to all they ...

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

A routine checkup in 2021 led to the discovery of Carter's genetic heart condition. He received a new heart just two days ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of ...

Researchers at the Yale School of Medicine (YSM) have developed a new screening test that pairs AI with portable cardiac ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Nearly 3 months after the FDA green-lit the TTR stabilizer, it joins tafamidis as the second therapy in Europe for the ...

The sudden death of a UNLV football player leaves the community seeking answers while young athletes reevaluate their own health.A report from the Las Vegas Met ...

The following is a summary of “Arrhythmogenic Right Ventricular Cardiomyopathy: the importance of biventricular strain in ...

The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Longview Regional Medical Center has scheduled free heart screenings Saturday for area youth ages 14 to 18. The screenings ...